CLEARONE INC
For the period ended Sep 30, 2024. Filed Nov 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 14, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Notes to Condensed Consolidated Financial Statements
- Business Description, Basis of Presentation and Significant Accounting Policies
Business Description:
ClearOne, Inc., together with its subsidiaries (collectively, “ClearOne” or the “Company”), is a global market leader enabling conferencing, collaboration, and AV streaming solutions for voice and visual communications. The performance and simplicity of our advanced, comprehensive solutions offer unprecedented levels of functionality, reliability and scalability.
Basis of Presentation:
The fiscal year for ClearOne is thetwelve months ending on December 31. The condensed consolidated financial statements include the accounts of ClearOne and its subsidiaries. All significant inter-company accounts and transactions have been eliminated.
These accompanying interim unaudited condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and are not audited. Certain information and footnote disclosures that are usually included in financial statements prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) have been either condensed or omitted in accordance with SEC rules and regulations. The accompanying condensed consolidated financial statements contain all adjustments, consisting of normal recurring accruals, necessary for a fair presentation of our financial position as of September 30, 2024 and December 31, 2023, the results of operations for thethree and nine months ended September 30, 2024 and 2023, and the cash flows for thenine months ended September 30, 2024 and 2023. The results of operations for thethree and nine months ended September 30, 2024 and 2023 are not necessarily indicative of the results for a full-year period. These interim unaudited condensed consolidated financial statements should be read in conjunction with the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC.
Significant Accounting Policies:
The significant accounting policies were described in Note 1 to the audited consolidated financial statements included in the Company’s annual report on Form 10-K for the year ended December 31, 2023. There have been no changes to these policies during the quarter ended September 30, 2024 that are of significance or potential significance to the Company.
Recent accounting pronouncements:
In December 2023, the FASB issued ASU 2023-09 “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” on the topic of income taxes. The standard requires additional disclosure for income taxes. These requirements include: (i) requiring a public entity to disclose specific categories in the rate reconciliation; (ii) disclosure of additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than 5% of the amount computed by multiplying pretax income or loss by the applicable statutory income tax rate); (iii) annual disclosure of the amount of income taxes paid (net of refunds received) disaggregated by federal (national), state, and foreign taxes; (iv) annual disclosure of the amount of income taxes paid (net of refunds received) disaggregated by individual jurisdictions in which income taxes paid (net of refunds received) is equal to or greater than 5% of total income taxes paid (net of refunds received); (v) annual disclosure of income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign; and (vi) annual disclosure of income tax expense (or benefit) from continuing operations disaggregated by federal (national), state, and foreign. For public entities, theguidance is effective for annual periods beginning after December 15, 2024. The Company will adopt this guidance in fiscal 2025 and is in the process of evaluating the new requirements. As a result, the Company has not yet determined the impact this new ASU will have on its disclosures.
The Company has determined that recently issued accounting standards, other than the above discussed, will not have a material impact on its consolidated financial position, results of operations or cash flows.
Liquidity:
As of September 30, 2024, our cash and cash equivalents were approximately $1,685 compared to $17,835 as of December 31, 2023. Our working capital was $19,712 as of September 30, 2024. Net cash used in operating activities was $4,575 for the nine months ended September 30, 2024, a decrease of $55,718 compared to $51,143 of cash provided by operating activities for thenine months ended September 30, 2023. The decrease in cash is mainly due to payment of dividends $14,496 in April 2024 and $28,979 in May 2023. These conditions raise substantial doubt about continuing as a going concern. The Company believes, although there can be no assurance, that the current cash position and effective management of working capital, will provide the liquidity needed to meet our operating needs through at least November 14, 2025. The Company also believes that its strong portfolio of intellectual property and its solid brand equity in the market will enable it to raise additional capital if and when needed to meet its short and long-term financing needs; however, there can be no assurance that, if needed, the Company will be successful in obtaining the necessary funds through equity or debt financing on favorable terms or at all. If the Company needs additional capital and is unable to secure financing, it may be required to further reduce expenses, or delay product development and enhancement.
- Revenue Information
The following table disaggregates the Company’s revenue into primary product groups:
| Three months ended September 30, | Nine months ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Audio conferencing | $929 | $1,867 | $3,357 | $6,484 |
| Microphones | 1,172 | 2,355 | 3,786 | 6,239 |
| Video products | 403 | 667 | 1,287 | 1,827 |
| $2,504 | $4,889 | $8,430 | $14,550 | |
The following table disaggregates the Company’s revenue into major regions:
| Three months ended September 30, | Nine months ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| North and South America | $932 | $2,400 | $3,236 | $7,353 |
| Asia Pacific (includes Middle East, India and Australia) | 1,358 | 2,058 | 4,200 | 5,426 |
| Europe and Africa | 214 | 431 | 994 | 1,771 |
| $2,504 | $4,889 | $8,430 | $14,550 | |
- Loss Per Share
Loss per common share is computed based on the weighted-average number of common shares outstanding and, when appropriate, dilutive potential common stock outstanding during the period. Stock options, warrants and the convertible portion of senior convertible notes are considered to be potential common stock. The computation of diluted loss per share does not assume exercise or conversion of securities that would have an anti-dilutive effect.
Basic loss per common share is the amount of net loss for the period available to each weighted-average share of common stock outstanding during the reporting period. Diluted loss per common share is the amount of loss for the period available to each weighted-average share of common stock outstanding during the reporting period and to each share of potential common stock outstanding during the period, unless inclusion of potential common stock would have an anti-dilutive effect.
The following table sets forth the computation of basic and diluted lossper common share:
| Three months ended September 30, | Nine months ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Numerator: | ||||
| Net loss | $(2,062) | $(1,351) | $(6,780) | $(3,202) |
| Denominator: | ||||
| Basic weighted average shares outstanding | 23,969,148 | 23,960,313 | 23,969,148 | 23,957,311 |
| Diluted weighted average shares outstanding | 23,969,148 | 23,960,313 | 23,969,148 | 23,957,311 |
| Basic loss per common share | $(0.09) | $(0.06) | $(0.28) | $(0.13) |
| Diluted loss per common share | $(0.09) | $(0.06) | $(0.28) | $(0.13) |
| Weighted average options, warrants and convertible portion of senior convertible notes outstanding | 5,515,489 | 6,294,994 | 5,579,061 | 6,316,137 |
| Anti-dilutive options, warrants and convertible portion of senior convertible notes not included in the computation | 5,515,489 | 6,294,994 | 5,579,061 | 6,316,137 |
- Marketable Securities
The Company has classified its marketable securities as available-for-sale securities. These securities are carried at estimated fair value with unrealized holding gains and losses included in accumulated other comprehensive loss in stockholders’ equity until realized. Gains and losses on marketable security transactions are reported on the specific-identification method. Dividend and interest income are recognized when earned.
The amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value for available-for-sale securities by major security type and class of securities as of September 30, 2024 and December 31, 2023 were as follows:
| Amortized cost | Gross unrealized holding gains | Gross unrealized holding losses | Estimated fair value | |
|---|---|---|---|---|
| Available-for-sale securities: | ||||
| Mutual funds | $1,150 | $4 | $(2) | $1,152 |
| Certificates of deposit | 206 | — | — | 206 |
| Total available-for-sale securities | $1,356 | $4 | $(2) | $1,358 |
| Amortized cost | Gross unrealized holding gains | Gross unrealized holding losses | Estimated fair value | |
|---|---|---|---|---|
| Available-for-sale securities: | ||||
| US Treasury securities | $1,804 | $— | $(1) | $1,803 |
| Mutual funds | 1,498 | 7 | — | 1,505 |
| Certificates of deposit | 103 | — | — | 103 |
| Corporate debt securities | $1,007 | $— | $(22) | $985 |
| Total available-for-sale securities | $4,412 | $7 | $(23) | $4,396 |
| Amortized cost | Estimated fair value | |
|---|---|---|
| Due within one year | $1,136 | $1,136 |
| Due after one year through five years | 220 | 222 |
| Total available-for-sale securities | $1,356 | $1,358 |
Debt securities in an unrealized loss position as of September 30, 2024 were not deemed impaired at acquisition and subsequent declines in fair value are not deemed attributed to declines in credit quality. Management believes that it is more likely than not that the securities will receive a full recovery of par value, although there can be no assurance that such recovery will occur. The available-for-sale marketable securities with continuous gross unrealized loss position for less than 12 months and 12 months or greater and their related fair values were as follows:
| Less than 12 months | More than 12 months | Total | ||||
|---|---|---|---|---|---|---|
| Estimated fair value | Gross unrealized holding losses | Estimated fair value | Gross unrealized holding losses | Estimated fair value | Gross unrealized holding losses | |
| Mutual Funds | $1,152 | $(2) | $— | $— | $1,152 | $(2) |
| Certificates of Deposit | 206 | — | — | — | 206 | — |
| Total | $1,358 | $(2) | $— | $— | $1,358 | $(2) |
| Less than 12 months | More than 12 months | Total | ||||
|---|---|---|---|---|---|---|
| Estimated fair value | Gross unrealized holding losses | Estimated fair value | Gross unrealized holding losses | Estimated fair value | Gross unrealized holding losses | |
| US Treasury securities | $1,803 | $(1) | $— | $— | $1,803 | $(1) |
| Mutual Funds | 1,505 | — | — | — | 1,505 | — |
| Certificates of Deposit | 103 | — | — | — | 103 | — |
| Corporate debt securities | 985 | (22) | — | — | 985 | (22) |
| Total | $4,396 | $(23) | $— | $— | $4,396 | $(23) |
- Intangible Assets
Intangible assets as of September 30, 2024 and December 31, 2023 consisted of the following:
| Estimated useful lives (years) · September 30, 2024 · December 31, 2023 | |||||
|---|---|---|---|---|---|
| Tradename | 5 | to | 7 | $555 | $555 |
| Patents and technological know-how | 10 | to | 20 | 7,275 | 7,187 |
| Proprietary software | 3 | to | 15 | 2,981 | 2,981 |
| Other | 3 | to | 5 | 323 | 324 |
| Total intangible assets | 11,134 | 11,047 | |||
| Accumulated amortization | (9,567) | (9,358) | |||
| Total intangible assets, net | $1,567 | $1,689 | |||
The amortization of intangible assets forthree and nine months ended September 30, 2024 and 2023 was as follows:
| Three months ended September 30, | Nine months ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Amortization of intangible assets | $49 | $141 | $209 | $388 |
The estimated future amortization expense of intangible assets is as follows:
| Years ending December 31, | Amount |
|---|---|
| 2024 (Remainder) | $50 |
| 2025 | 199 |
| 2026 | 199 |
| 2027 | 69 |
| 2028 | 24 |
| Thereafter | 1,026 |
| Total | $1,567 |
- Inventories
Inventories, net of reserves, as of September 30, 2024 and December 31, 2023 consisted of the following:
| September 30, 2024 | December 31, 2023 | |
|---|---|---|
| Current: | ||
| Raw materials | $1,316 | $2,086 |
| Finished goods | 12,953 | 8,539 |
| $14,269 | $10,625 | |
| Long-term: | ||
| Raw materials | $909 | $1,789 |
| Finished goods | 1,328 | 1,354 |
| $2,237 | $3,143 | |
Long-term inventory represents inventory held in excess of our current (next 12 months) requirements based on our recent sales and forecasted level of sales. We expect to sell the above inventory, net of reserves, at or above the stated cost and believe that no loss will be incurred on its sale, although there can be no assurance of the timing or amount of any sales.
Net loss incurred on valuation of inventory at lower of cost or market value and write-off of obsolete inventory forthree and nine months ended September 30, 2024 and 2023 was as follows:
| Three months ended September 30, | Nine months ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Net loss (gain) incurred on valuation of inventory at lower of cost or market value and write-off of obsolete inventory | $(6) | $3 | $(92) | $105 |
- Leases
Rent expense is recognized on a straight-line basis over the period of the lease taking into account future rent escalation and holiday periods.
Rent expense forthree and nine months ended September 30, 2024 and 2023 was as follows:
| Three months ended September 30, | Nine months ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Rent expense | $116 | $110 | $343 | $369 |
The Company occupies a 1,350 square-foot facility in Gainesville, Florida under the terms of an operating lease expiring in February 2028. The Gainesville facility is used primarily to support the Company's research and development activities.
The Company occupies a 9,402 square-foot facility in Salt Lake City, Utah under the terms of an operating lease expiring in February 2028. The facility supportsthe Company's principal administrative, sales, marketing, customer support, and research and product development activities.
The Company occupies a 6,175 square-foot facility in Chennai, India under the terms of an operating lease which expired in August 2024. This facility supports the Company'sadministrative, marketing, customer support, and research and product development activities. The lease is currently operating on a month-to-month basis. The Company is planning to renew the lease.
The Company occupies a 40,000 square-foot warehouse in Salt Lake City, Utah under the terms of an operating lease expiring in April 2025, which serves as the Company's primary inventory fulfillment center.
Supplemental cash flow information related to leases was as follows:
| Nine months ended September 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash paid for amounts included in the measurement of lease liabilities | ||
| Operating cash flows from operating leases | $338 | $378 |
| Right-of-use assets obtained in exchange for lease obligations: | ||
| Operating leases | $— | $341 |
Supplemental balance sheet information related to leases was as follows:
| September 30, 2024 | December 31, 2023 | |
|---|---|---|
| Operating lease right-of-use assets | $718 | $990 |
| Current portion of operating lease liabilities, included in accrued liabilities | $282 | $383 |
| Operating lease liabilities, net of current portion | 472 | 665 |
| Total operating lease liabilities | $754 | $1,048 |
| Weighted average remaining lease term for operating leases (in years) | 3.01 | 3.39 |
| Weighted average discount rate for operating leases | 6.62% | 6.47% |
The following represents maturities of operating lease liabilities as of September 30, 2024:
| Years ending December 31, | |
|---|---|
| 2024 (Remainder) | $101 |
| 2025 | 272 |
| 2026 | 210 |
| 2027 | 216 |
| 2028 | 36 |
| Total lease payments | 835 |
| Less: Imputed interest | 81 |
| Total | $754 |
- Shareholders' Equity
| Three months ended September 30, | Nine months ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Common stock and additional paid-in capital | ||||
| Balance, beginning of period | $31,640 | $46,003 | $46,071 | $74,934 |
| Dividends declared | — | — | (14,496) | (28,979) |
| Share-based compensation expense | 21 | 33 | 73 | 80 |
| Proceeds from employee stock purchase plan | 3 | 3 | 16 | 4 |
| Balance, end of period | $31,664 | $46,039 | $31,664 | $46,039 |
| Accumulated other comprehensive loss | ||||
| Balance, beginning of period | $(294) | $(270) | $(310) | $(288) |
| Unrealized loss on available-for-sale securities, net of tax | (1) | (31) | 18 | (17) |
| Foreign currency translation adjustment | (12) | (7) | (15) | (3) |
| Balance, end of period | $(307) | $(308) | $(307) | $(308) |
| Accumulated deficit | ||||
| Balance, beginning of period | $(5,794) | $(2,367) | $(1,076) | $(516) |
| Net loss | (2,062) | (1,351) | (6,780) | (3,202) |
| Balance, end of period | $(7,856) | $(3,718) | $(7,856) | $(3,718) |
| Total shareholders' equity | $23,501 | $42,013 | $23,501 | $42,013 |
Issue of Common Stock and Warrants
On September 12, 2021, the Company entered into a securities purchase agreement with certain purchasers named therein, pursuant to which the Company issued 3,623,189 shares of the Company's common stock, par value $0.001 per share at an offering price of $2.76 per share. The Company received gross proceeds of approximately $10,000 and net proceeds of $9,288 after deducting placement agent fees and related offering expenses. In a concurring private placement the Company also issued to the same purchasers warrants exercisable for an aggregate of 3,623,189 shares of common stock at an exercise price of $2.76 per share. Each warrant became immediately exercisable and will expire on March 15, 2027.
On January 4, 2022, the Company entered into a Securities Purchase Agreement with Edward D. Bagley, an affiliate of the Company, pursuant to which the Company agreed to issue and sell, in a private placement 1,538,461 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share, at a purchase price of $1.30 per share of Common Stock. The consideration for the Shares is the cancellation and termination of Mr. Bagley’s outstanding bridge loan to the Company in the principal amount of $2,000 originally issued on July 2, 2021 and amended and restated on September 11, 2021. Mr. Bagley is an affiliate of the Company and the Company’s single largest stockholder.
- Share-based Compensation
The Company uses judgment in determining the fair value of the share-based payments on the date of grant using an option-pricing model with assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, the risk-free interest rate of the awards, the expected life of the awards, the expected volatility over the term of the awards, and the expected dividends of the awards. The Company uses the Black-Scholes option pricing model to determine the fair value of share-based payments granted under the guidelines of ASC Topic 718.
A summary of the stock option activity under the Company’s plans for thenine months ended September 30, 2024, is as follows:
| Number of shares | Weighted average exercise price | |
|---|---|---|
| Options outstanding at beginning of year | 607,810 | $5.03 |
| Granted | — | — |
| Less: | ||
| Exercised | — | — |
| Forfeited prior to vesting | (20,000) | 1.01 |
| Canceled or expired | (121,126) | 8.08 |
| Options outstanding at September 30, 2024 | 466,684 | 4.41 |
| Options exercisable at end of September 30, 2024 | 364,163 | $5.33 |
As of September 30, 2024, the total remaining unrecognized compensation cost related to non-vested stock options, net of forfeitures, was approximately $77, which will be recognized over a weighted average period of 2.2 years.
Share based compensation expense has been recorded as follows:
| Three months ended September 30, | Nine months ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Cost of goods sold | $2 | $2 | $6 | $5 |
| Sales and marketing | 2 | 2 | 9 | 6 |
| Research and product development | 14 | 17 | 38 | 37 |
| General and administrative | 3 | 12 | 20 | 32 |
| $21 | $33 | $73 | $80 | |
- Income Taxes
The Company recorded a full valuation allowance against U.S Federal and State deferred tax assets, which results in no income tax benefit for losses in these jurisdictions. The full domestic valuation allowance was recorded as management concluded that it is more likely than not that these deferred tax assets are not realizable due to the Company's recent pre-tax losses and other sources of negative evidence. Provision for income taxes for thenine months ended September 30, 2024 mostly represents income tax expense (benefit) recorded for jurisdictions outside the United States.
The Company had approximately $1,079 of uncertain tax positions as of September 30, 2024. Due to the inherent uncertainty of the underlying tax positions, it is not possible to forecast the payment of this liability for any particular year, therefore, it is reflected in other long-term liabilities.
11. Fair Value Measurements
The fair value of the Company’s financial instruments reflects the amounts that the Company estimates it will receive in connection with the sale of an asset or pay in connection with the transfer of a liability in an orderly transaction between market participants at the measurement date (exit price). The fair value hierarchy prioritizes the use of inputs used in valuation techniques into the following three levels:
Level 1 - Quoted prices in active markets for identical assets and liabilities.
Level 2 - Observable inputs other than quoted prices in active markets for identical assets and liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. This category generally includes U.S. Government and agency securities; municipal securities; mutual funds and securities sold and not yet settled.
Level 3 - Unobservable inputs.
The Company’s financial instruments are valued using observable inputs. The following table sets forth the fair value of the financial instruments re-measured by the Company as of September 30, 2024:
| Level 1 | Level 2 | Level 3 | Total | |
|---|---|---|---|---|
| Mutual funds | $1,152 | $— | $— | $1,152 |
| Certificates of deposit | — | 206 | — | 206 |
| Total | $1,152 | $206 | $— | $1,358 |
| Level 1 | Level 2 | Level 3 | Total | |
|---|---|---|---|---|
| Mutual funds | $1,505 | $— | $— | $1,505 |
| US Treasury securities | — | 1,803 | — | 1,803 |
| Certificates of deposit | — | 103 | — | 103 |
| Corporate debt securities | — | 985 | — | 985 |
| Total | $1,505 | $2,891 | $— | $4,396 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.